How to reignite the fight against the nation’s opioid epidemic
The COVID-19 crisis is far from over, yet the opioid epidemic continues to flare. The AMA details steps states should take, and calls on CDC to revise its opioid prescribing guideline.
Dr. Harris made big mark as AMA president, but her work’s not over
In this Q&A, learn what AMA Immediate Past President Patrice A. Harris, MD, MA, sees in the year ahead for patients and physicians.
AMA COVID-19 daily video update: Experts discuss the pandemic’s impact on the opioid epidemic
The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.
COVID-19 may be worsening opioid crisis, but states can take action
The pandemic is exacerbating the ongoing opioid epidemic. The AMA is calling on states to take specific steps to save lives, reduce harm and get patients treatment they need.
AMA recommends exceptions to facilitate opioid use disorder treatment
The blanket exception will allow patients to obtain up to 28 days of take-home medication if they are stable and up to 14 days for patients who are less stable.
New York effort raises use of MAT for opioid-use disorder
Medications for addiction treatment (MAT) are underused, with racial, geographic and economic barriers. Learn about a Big Apple initiative that’s making big changes.
After his son’s death, Massachusetts physician seeks to help others
James Baker, MD, whose son died of an overdose at 23, provides phone support to primary care doctors treating patients with substance-use disorders.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights